U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. ZEMAIRA
  1. Approved Blood Products

STN: 125078
Proper Name: Alpha-1-Proteinase Inhibitor (Human)
Tradename: ZEMAIRA
Manufacturer: CSL Behring LLC
Indication: 

  • Use as chronic augmentation and maintenance therapy in individuals with Alpha-1-Antitrypsin Deficiency and evidence of emphysema.

Product Information

Supporting Documents

Back to Top